PharmaCielo Ltd.

Latest

Aug 27, 2019, 07:00 ET PharmaCielo Announces Financial Results for the Second Quarter 2019

Well capitalized with a cash and short-term investments of $33.2 million as of June 30, 2019 Subsequent to quarter completed first commercial export of CBD from Colombia to Europe Have cleared all...


Aug 19, 2019, 08:00 ET PharmaCielo's Very First Commercial CBD Export from Colombia Lands in Europe

Commercial shipment delivers CBD isolate to Switzerland-based Creso Pharma Company executed overseas commercial delivery weeks after securing the first commercial exporting permit from Colombian...


Aug 13, 2019, 08:00 ET PharmaCielo Expands Further Into Latin America With Sales Agreement to Supply CBD Extracts, Oils and Veterinary Products to Laboratorios Adler

CBD extracts and oils to be used in Adler's portfolio of veterinary products for pain and cancer treatment in large and domestic animals Agreement also includes supply of Creso Pharma's anibidiol®...


Aug 08, 2019, 08:00 ET PharmaCielo Joins Canadian Market Cannabis Tracking and Verification Initiative

PharmaCielo is the first non-Canadian medical cannabis producer to join the Canadian Pilot Program TruTrace's technology offers full transparency and traceability of medical cannabis from the plant's ...


Aug 02, 2019, 08:00 ET PharmaCielo Colombia Holdings S.A.S. Appoints New and Diversified Board of Directors

New board consists of diversified experts with domestic and international business, academia, agriculture, trade and healthcare expertise Half of new board members are businesswomen, reflecting the...


Aug 01, 2019, 08:00 ET PharmaCielo Achieves Twelvefold Increase in Dried Cannabis Processing Capacity to Meet Global Demand for Medicinal Oil Extracts

Investment of CDN$4 million expands Colombian processing capabilities twelvefold through addition of high-volume extraction equipment and proprietary techniques Annual extraction capacity increased...


Jul 26, 2019, 08:10 ET PharmaCielo Completes Acquisition of Ubiquo Telemedicina

Ubiquo Telemedicina S.A.S. is a leading provider of telemedicine services in Colombia Acquisition will enable expanded access to medicinal cannabis expertise among the Colombian medical community...


Jul 25, 2019, 08:10 ET PharmaCielo First to Receive Colombian Government Export Approval for Commercial Sale of CBD Isolate

Completion of commercial export permit process clears the way for PharmaCielo to initiate shipment of its medicinal-grade CBD extracts to wholesale distributors and product manufacturers CBD isolate...


Jul 22, 2019, 07:30 ET PharmaCielo Colombia Holdings S.A.S. Appoints Andres Felipe Botero as Chief Operations Officer

Mr. Botero brings nearly two decades of domestic and international operational experience with industry giant Philip Morris International, most recently as Director of Operations for the Andean...


Jun 21, 2019, 08:00 ET PharmaCielo Announces Trading on the OTC Market

TORONTO and RIONEGRO, Colombia, June 21, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO) (OTC:PHCEF), the Canadian parent of Colombia's premier cultivator and producer of...


Jun 06, 2019, 10:30 ET PharmaCielo to Acquire International Cannabis Company Creso Pharma for A$122 Million

Acquisition will add extensive on-shelf product portfolio available in multiple regions Expands PharmaCielo's global sales reach and market presence in Canada, Switzerland, Europe, Australia, New...


May 29, 2019, 07:00 ET PharmaCielo Gears Up for U.S. Market Demand, Enlists Former Congressman and Medical Cannabis Advocate Dana Rohrabacher as a Special Advisor

Rohrabacher is a longstanding advocate for the legalization of medical cannabis Rohrabacher spearheaded historic U.S. legislation that protects medical cannabis patients TORONTO, May 29, 2019 /CNW/ - ...


May 27, 2019, 07:00 ET PharmaCielo Announces its Financial Results for the First Quarter 2019

Well capitalized with a cash and cash equivalents balance of $40.8 million as of March 31, 2019 Working towards first commercial sales in the 2nd half of 2019 Area under cultivation has grown to ~12...


May 24, 2019, 07:00 ET PharmaCielo Announces Results of AGM

TORONTO and RIONEGRO, Colombia, May 24, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of...


Apr 18, 2019, 07:50 ET PharmaCielo Announces Its Financial Results for the Fourth Quarter and Fiscal Year 2018

PharmaCielo expects to begin commercial sales in 2019. Oil processing facility is on track for commercial operation and GMP certification during Q3-2019, enabling large-scale production and sale of...


Apr 09, 2019, 07:00 ET PharmaCielo Appoints New and Extended Medical and Scientific Advisory Board

International panel of renowned physicians, researchers, veterinarians, engineers and academics Advisory Board to guide PharmaCielo's research and development of special cannabinoids-based...


Mar 29, 2019, 08:00 ET PharmaCielo Doubles Its Portfolio of Proprietary Cannabis Strains Approved for Colombia's Cultivar Registration

Adds 10 new THC-dominant strains to previously approved group, including unique 1:1 ratio strain Company holds the largest and most diversified portfolio of cultivar-registered strains in Colombia...


Mar 19, 2019, 08:00 ET PharmaCielo Receives ISO 9001 Quality Assurance Certification for Its Medicinal Cannabis Cultivation and Processing Operations in Colombia

PharmaCielo is the first and only Colombian cannabis company to receive the internationally recognized ISO 9001:2015 certification ISO 9001 certification affirms the company's commitment to producing ...


Feb 06, 2019, 06:30 ET PharmaCielo Receives Approval for Cultivar Registration of 10 Proprietary Cannabis Strains

Colombia's only CBD-dominant strain meeting WHO purity standards among strains approved Establishes unique competitive advantage as sole licensed producer in Colombia of non-psychoactive strain WHO...


Jan 28, 2019, 06:30 ET PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico

Joint venture secures PharmaCielo's foothold in world's largest legalized medicinal cannabis marketplace with population of 130-million and over 33,0001medicinal distribution points Marks key step in ...


Jan 18, 2019, 07:50 ET PharmaCielo Begins Trading on the TSX Venture Exchange Under Ticker PCLO

PharmaCielo to begin trading on the TSX Venture Exchange ("TSXV" or "TSX Venture") under the Ticker PCLO at market open today, January 18, 2019. In the process of scaling its area under current...


Jan 16, 2019, 20:25 ET PharmaCielo Ltd. Announces Completion of Qualifying Transaction

/THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ TORONTO, Jan. 16, 2019 /CNW/ - PharmaCielo Ltd. (the "Company" or...


Jan 09, 2019, 15:50 ET PharmaCielo Announces TSX Venture Listing and Provides Corporate Update

PharmaCielo to begin trading on the TSX Venture Exchange ("TSXV" or "TSX Venture") under the Ticker PCLO on or about January 18, 2019. Management team and board of directors in place to support...


Dec 13, 2018, 16:30 ET PharmaCielo to Produce 500-Year-Old Cannabis Strain in the Ancestral Territory of the Arhuaco

The Company has partnered with indigenous peoples in Colombia such as the Arhuaco, to bring opportunity to historically disadvantaged areas of the country through the production and sale of legal...


Sep 10, 2018, 08:00 ET PharmaCielo Announces David Gordon as Chief Corporate Officer

TORONTO and MEDELLIN, Colombia, Sept. 10, 2018 /CNW/ - Anthony Wile, CEO of PharmaCielo Ltd. ("the Company") is pleased to announce that David Gordon has been appointed its Chief Corporate Officer...